Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1421696 | 0.98 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNACES2CES1TSHR | |
| Hydrochloric Acid SCHEMBL27538885 | 0.98 | SMN1; SMN2 (0.41) | SMN1; SMN2LMNACES2CES1TSHR | |
| SCHEMBL10260369 | 0.98 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNACES2CES1TSHR | |
| SCHEMBL10260332 | 0.98 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNACES2CES1TSHR | |
| SCHEMBL28284573 | 0.96 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNACES2CES1TSHR | |
| SCHEMBL10260350 | 0.95 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNACES2CES1TSHR | |
| Hydrochloric Acid SCHEMBL28526029 | 0.94 | SMN1; SMN2 (0.42) | SMN1; SMN2LMNACES2CES1TSHR | |
| SCHEMBL1296764 | 0.90 | TSHR (0.43) | SMN1; SMN2LMNATSHRKMT2AALDH1A1 | |
| SCHEMBL2657918 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL27570998 | 0.88 | TSHR (0.42) | SMN1; SMN2LMNATSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3713415-A1 | PESTICIDE COMPOSITIONS | Fundació Centre de Regulació Genòmica (ES) | 2020-09-30 | — | — | EP | claimed |
| WO-2019101890-A1 | PESTICIDE COMPOSITIONS | FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA (ES) | 2019-05-31 | — | — | WO | claimed |
| CN-101535276-B | 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors | CEPHALON INC | 2013-08-28 | — | — | CN | claimed |
| CN-101535276-A | 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors | CEPHALON INC (US) | 2009-09-16 | — | — | CN | claimed |
| CN-101287472-A | Antiviral 4'-substituted pre-nucleotide phosphoramidates | ROCHE PALO ALTO LLC (CH) | 2008-10-15 | — | — | CN | claimed |
| US-12041848-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
| US-11779015-B2 | Pesticide compositions | FUNDACIÓ CENTRE DE REGULACIÓ GENÓMICA (ES) | 2023-10-10 | — | — | US | disclosed |
| US-11711971-B2 | Ink composition and method for manufacturing organic light emitting device | LG CHEM, LTD. | 2023-07-25 | — | — | US | disclosed |
| US-20230174544-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| US-11641778-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-05-02 | — | — | US | disclosed |
| US-11641778-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-05-02 | — | — | US | disclosed |
| WO-2023020523-A1 | BICYCLIC DERIVATIVES AND USE THEREOF | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2023-02-23 | — | — | WO | disclosed |
| CN-1805965-A | Modulators of chemokine receptor activity | MERCK & CO INC (US) | 2006-07-19 | — | — | CN | disclosed |
| CN-1802187-A | Benzoxazinyl-amido cyclopentyl-heterocyclic modulators of chemokine receptors | MERCK & CO INC (US) | 2006-07-12 | — | — | CN | disclosed |
| EP-1660427-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2006-05-31 | — | — | EP | disclosed |
| US-6867320-B2 | Substituted phenylalkanoic acid derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2005-03-15 | — | — | US | disclosed |
| WO-2005016862-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORPORATION (JP) | 2005-02-24 | — | — | WO | disclosed |
| EP-1477472-A1 | SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2004-11-17 | — | — | EP | disclosed |
| US-20040044258-A1 | Substituted phenylalkanoic acid derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-03-04 | — | — | US | disclosed |
| CN-1248259-A | Fused pyridazine derivatives, process for producing the same and use thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2000-03-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11641778-B2 | Compound and organic light emitting device comprising same | CRY1, CYP1A1, CRY2 | SMN1; SMN2 4261/4885LMNA 4053/4885CES2 761/4885 |
| US-12041848-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, NR2E3 | SMN1; SMN2 2961/4885LMNA 2975/4885CES2 2101/4885 |
| US-20230174544-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY2, CYBA, AHR | SMN1; SMN2 3917/4885LMNA 1053/4885CES2 1632/4885 |
| US-20040044258-A1 | Substituted phenylalkanoic acid derivatives and use thereof | PTGER1, CYSLTR1, PTGS1 | SMN1; SMN2 4713/4885LMNA 820/4885CES2 1879/4885 |
| US-11779015-B2 | Pesticide compositions | ADH1C, DDT, AKR1C3 | SMN1; SMN2 4447/4885LMNA 3581/4885CES2 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.